Real-time electrochemical monitoring of drug release from therapeutic nanoparticles

Journal of Controlled Release

Volumn 140, Issue 1, 2009, Pages 69-73

  Mora, Laura ^a,c   Chumbimuni Torres, Karin Y ^a   Clawson, Corbin ^b   Hernandez, Lucas ^c   Zhang, Liangfang ^a   Wang, Joseph ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Doxorubicin; Drug release; Liposome; Nanomedicine; Nanoparticles; Real time monitoring; Voltammetry

Indexed keywords

ANALYTICAL TOOL; CONTINUOUS MEASUREMENTS; CONTINUOUS MONITORING; DILUTED SERUM; DOXORUBICIN; DRUG RELEASE; DRUG RELEASE KINETICS; DRUG RELEASE PROPERTIES; ELECTROCHEMICAL MONITORING; GLASSY CARBON ELECTRODES; HIGH SENSITIVITY; HYDROPHOBIC DRUG; NANOMEDICINE; REAL TIME; REAL-TIME MONITORING; SQUARE-WAVE; VOLTAMMETRIC MEASUREMENTS; WATER SOLUBILITIES;

BIOELECTRIC PHENOMENA; DRUG DELIVERY; LIPOSOMES; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; PHOSPHOLIPIDS; VOLTAMMETRY;

MONITORING;

DOXORUBICIN; NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG SOLUBILITY; ELECTROCHEMICAL ANALYSIS; POTENTIOMETRY; PRIORITY JOURNAL; RELIABILITY;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG MONITORING; ELECTROCHEMISTRY; KINETICS; LIPOSOMES; NANOMEDICINE; NANOPARTICLES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 70349823215     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.08.002     Document Type: Article

References (24)

1. Peer D., Karp J.M., Hong S., FaroKHzad O.C., Margalit R., and Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotech. 2 (2007) 751-760
2. Davis M.E., Chen Z.G., and Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7 (2008) 771-782
3. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., and Farokhzad O.C. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83 (2008) 761-769
4. Wagner V., Dullaart A., Bock A.K., and Zweck A. The emerging nanomedicine landscape. Nat. Biotech. 24 (2006) 1211-1217
5. Langer R. Drug delivery and targeting. Nature 392 (1998) 5-10
6. Zhang L.F., Chan J.M., Gu F.X., Rhee J.W., Wang A.Z., Radovic-Moreno A.F., Alexis F., Langer R., and Farokhzad O.C. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2 (2008) 1696-1702
7. Schwartz H.S. A fluorometric assay for daunomycin and adriamycin in animal tissues. Biochem. Med. 7 (1973) 396-404
8. Van Vunakis H., Langone J.J., Riceberg L.J., and Levine L. Radioimmunoassays for adriamycin and daunomycin. Cancer Res. 34 (1974) 2546-2552
9. Zagotto G., Gatto B., Moro S., Sissi C., and Palumbo M. Anthracyclines: recent developments in their separation and quantitation. J. Chromatogr. B 764 (2001) 161-171
10. Pierce R.N., and Jatlow P.I. Measurement of adriamycin (doxorubicin) and its metabolites in human-plasma using reversed-phase high-performance liquid-chromatography and fluorescence detection. J. Chromatogr. 164 (1979) 471-478
11. Kissinger P.T. Amperometric and coulometric detectors for high-performance liquid-chromatography. Anal. Chem. 49 (1977) A447-452
12. Lurie I.S. Problems in using high performance liquid chromatography for drug analysis. J. Forensic Sci. 29 (1984) 4
13. Chan J.M., Zhang L., Yuet K.P., Liao G., Rhee J.W., Langer R., and Farokhzad O.C. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 30 (2009) 1627-1634
14. Tan J.P.K., and Tam K.C. Application of drug selective electrode in the drug release study of pH-responsive microgels. J. Control Release 118 (2007) 87-94
15. Wang J. Real-time electrochemical monitoring: toward green analytical chemistry. Accounts Chem. Res. 35 (2002) 811-816
16. Wang J., Hutchins L.D., Selim S., and Cummins L.B. Long voltammetric microelectrode for in vivo monitoring of acetaminophen in primate species. Bioelectrochem. Bioenerg. 12 (1984) 193-203
17. Hahn Y., and Lee H.Y. Electrochemical behavior and square wave voltammetric determination of doxorubicin hydrochloride. Arch. Pharm. Res. 27 (2004) 31-34
18. O'Brien M.E.R. Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer. Anti-Cancer Drugs 19 (2008) 1-7
19. Baldwin R.P., Packett D., and Woodcock T.M. Electrochemical-behavior of adriamycin at carbon paste electrodes. Anal. Chem. 53 (1981) 540-542
20. Komorsky-Lovric S. Redox kinetics of adriamycin adsorbed on the surface of graphite and mercury electrodes. Bioelectrochemistry 69 (2006) 82-87
21. Yi C., and Gratzl M. Continuous in situ electrochemical monitoring of doxorubicin efflux from sensitive and drug-resistant cancer cells. Biophys. J. 75 (1998) 2255-2261
22. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
23. Alexopoulos A., Karamouzis M.V., Stavrinides H., Ardavanis A., Kandilis K., Stavrakakis J., Georganta C., and Rigatos G. Phase II study of pegylated liposomal doxorubicin (Caelyx) and docetaxel as first-line treatment in metastatic breast cancer. Ann. Oncol. 15 (2004) 891-895
24. Wrasidlo W., Mielgo A., Torres V.A., Barbero S., Stoletov K., Suyama T.L., Klemke R.L., Gerwick W.H., Carson D.A., and Stupack D.G. The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc. Natl. Acad. Sci. USA 105 (2008) 2313-2318